Do you want to read an article? Please log in or register.
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update
Genitourinary Cancer
Related content
COMMENTED
Genitourinary Cancer
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
Eur Urol
Cathomas R, Lorch A, Bruins HM, Compérat EM, Cowan NC, Efstathiou JA, Fietkau R, Gakis G, Hernández V, Espinós EL, Neuzillet Y, Ribal MJ, Rouanne M, Thalmann GN, van der Heijden AG, Veskimäe E, Alfred Witjes J, Milowsky MI, EAU Muscle-invasive, Metastatic Bladder Cancer Guidelines Panel.
doi: 10.1016/j.eururo.2021.09.026
Genitourinary Cancer
European Association of Urology Guidelines on Primary Urethral Carcinoma-2020 Update
Eur Urol Oncol.
Gakis G, Bruins HM, Cathomas R, Compérat EM, Cowan NC, van der Heijden AG, Hernández V, Linares Espinós EE, Lorch A, Neuzillet Y, Ribal MJ, Rouanne M, Thalmann GN, Veskimäe E, Witjes AJ
doi: 10.1016/j.euo.2020.06.003.
Genitourinary Cancer
Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy
Eur Urol.
Leow JJ, Chong YL, Chang SL, Valderrama BP, Powles T, Bellmunt J
doi: 10.1016/j.eururo.2020.07.003.
Genitourinary Cancer
Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma
Eur Urol.
Bex A, Albiges L, Ljungberg B, Bensalah K, Dabestani S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Lam TB, Marconi L, Merseburger AS, Fernández-Pello S, Tahbaz R, Abu-Ghanem Y, Staehler M, Volpe A, Powles T
doi: 10.1016/j.eururo.2018.08.008.
Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future Direction
J Urol.
Redrow GP, Guo CC, Brausi MA, Coleman JA, Fernandez MI, Kassouf W, Keeley FX Jr, Margulis V, Raman JD, Roupret M, Shariat SF, Spiess PE, Thalmann GN, Matin SF
doi: 10.1016/j.juro.2016.03.194.
Genitourinary Cancer
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial
Lancet Oncol.
Kleinmann N, Matin SF, Pierorazio PM, Gore JL, Shabsigh A, Hu B, Chamie K, Godoy G, Hubosky S, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Stern J, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Adibi M, Amin MB, Seltzer E, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Schoenberg M, Lerner SP
doi: 10.1016/S1470-2045(20)30147-9.
Genitourinary Cancer
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial
doi: 10.1016/S0140-6736(20)30415-3.
Genitourinary Cancer
MicroRNA expression profiles in upper tract urothelial carcinoma differentiate tumor grade, stage and survival: implications for clinical decision-making
Urology.
Browne BM, Stensland KD, Patel CK, Sullivan T, Burks EJ, Canes D, Raman JD, Warrick J, Reiger-Christ KM
doi: 10.1016/
Genitourinary Cancer
Swiss experience of atezolizumab for platinum-pretreated urinary tract carcinoma: the SAUL study in real-world practice
Swiss Med Wkly.
Cathomas R, Schardt J, Pless M, Llado A, Mach N, Riklin C, Haefeli J, Fear S, Stenner F
doi: 10.4414/smw.2020.20223.